Is INO up or down today?
INO is down 21.95% today, last at 0.6024. This stock moved -21.95% versus the prior close.
INO · INO
INO (INO) is trading at 0.6024, down 21.95% on the session. INO sits at the 2% mark of its 52-week range, carries a 14-day RSI of 27, and trades below its 50-day average. Over the past month it is down 50.21%.
Leading the coverage: “Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch” (Google News Company, 5d ago). INO is -30.76% since story.
INO trades on a trailing P/E of 45.2 and is running 49.13% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
INO is down 21.95% today, last at 0.6024. This stock moved -21.95% versus the prior close.
Leading the coverage: “Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch” (Google News Company, 5d ago). INO is -30.76% since story. Dominant story: Inovio Pharmaceuticals, Inc. (INO) Stock Price, News, Quote & History - Yahoo! Finance Canada (3 sources, neutral) RSI is 27 — oversold (beaten down) Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Oct 2026 (126 days) · Drag or scroll left for earlier dates
Inovio Pharmaceuticals, Inc. (INO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Inovio Pharmaceuticals Surges After VOCERYQ Wins FDA Approval - StocksToTrade
Inovio Pharmaceuticals Gets FDA Accelerated Approval for VOCERYQ
Inovio Pharmaceuticals, Inc. (INO) stock price, news, quote and history - Yahoo Finance UK
PGEN Stock Craters 27% After-Hours After Rival Inovio's Rare Disease Drug Receives FDA Approval - Yahoo Finance